methylprednisolone has been researched along with piperacillin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hsu, S; Kass, JS; Krishnan, RS; Lewis, AT | 1 |
| Marcille, R; Sakarcan, A; Stallworth, J | 1 |
| Cetinkaya, RA; Coşkun, O; Eyigün, CP; Görenek, L; Ide, T; Kiliç, S; Senses, Z | 1 |
| Daniels, H; Delforge, M; Martens, PJ | 1 |
| Boardman, EA; Sohail, S; Yadavilli, R | 1 |
| Abu-Abed, S; Chan, B; Del Paggio, JC; Ellis, AK; Rawls, M; Rosen, A | 1 |
1 review(s) available for methylprednisolone and piperacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for methylprednisolone and piperacillin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Eruptions; Erythema; Female; Humans; Methylprednisolone; Penicillins; Piperacillin; Tobramycin; Ultraviolet Rays | 2001 |
Antibiotic-induced recurring interstitial nephritis.
Topics: Adolescent; Biopsy; Clavulanic Acids; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Kidney; Methylprednisolone; Nephritis, Interstitial; Penicillins; Piperacillin; Ticarcillin | 2002 |
The effect of methylprednisolone on treatment in rats with induced sepsis.
Topics: Animals; Disease Models, Animal; Methylprednisolone; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Sepsis | 2009 |
Lymphoproliferative associated type 1 cryoglobulinemia.
Topics: Aged, 80 and over; Biopsy; Cryoglobulinemia; Humans; Immunoglobulin M; Immunohistochemistry; Lymphoproliferative Disorders; Male; Methylprednisolone; Penicillanic Acid; Piperacillin; Rituximab; Tazobactam | 2016 |
Goodpasture's disease with late presentation of renal abnormality and anti-GBM autoantibody.
Topics: Adolescent; Angiography; Anti-Bacterial Agents; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Glomerulonephritis; Glucocorticoids; Hemoptysis; Humans; Male; Methylprednisolone; Piperacillin; Pneumonia; Tomography, X-Ray Computed | 2017 |
Acute generalized exanthematous pustulosis with multisystem manifestations: Pinpoint pustules and purulent lakes.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Allergens; Betamethasone Valerate; Bodily Secretions; Diagnosis, Differential; Eosinophils; Erythema; Female; Humans; Methylprednisolone; Neutrophils; Piperacillin; Psoriasis; Tazobactam | 2018 |